Premier Fund Managers Ltd Invests $709,000 in Stevanato Group S.p.A. (NYSE:STVN)

Premier Fund Managers Ltd purchased a new position in shares of Stevanato Group S.p.A. (NYSE:STVN - Free Report) during the first quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 34,951 shares of the company's stock, valued at approximately $709,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Bessemer Group Inc. raised its position in Stevanato Group by 14,623.3% in the 1st quarter. Bessemer Group Inc. now owns 13,251 shares of the company's stock valued at $270,000 after buying an additional 13,161 shares during the last quarter. Palisade Capital Management LP raised its holdings in shares of Stevanato Group by 52.0% in the first quarter. Palisade Capital Management LP now owns 91,431 shares of the company's stock valued at $1,867,000 after purchasing an additional 31,283 shares during the last quarter. D. E. Shaw & Co. Inc. bought a new position in shares of Stevanato Group during the fourth quarter valued at about $281,000. Envestnet Asset Management Inc. boosted its holdings in Stevanato Group by 16.9% during the first quarter. Envestnet Asset Management Inc. now owns 162,770 shares of the company's stock worth $3,324,000 after purchasing an additional 23,545 shares during the last quarter. Finally, Yarbrough Capital LLC purchased a new position in Stevanato Group during the first quarter worth about $329,000.

Stevanato Group Stock Performance

Shares of NYSE:STVN traded up €0.43 ($0.50) during mid-day trading on Friday, reaching €25.14 ($29.23). The company had a trading volume of 551,500 shares, compared to its average volume of 337,123. The company's 50-day moving average price is €24.37 and its 200-day moving average price is €22.38. Stevanato Group S.p.A. has a one year low of €17.12 ($19.91) and a one year high of €28.00 ($32.56). The firm has a market cap of $7.61 billion, a price-to-earnings ratio of 49.30, a PEG ratio of 2.48 and a beta of 0.55. The company has a current ratio of 1.83, a quick ratio of 1.26 and a debt-to-equity ratio of 0.22.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on STVN shares. Stephens raised shares of Stevanato Group to a "strong-buy" rating in a research report on Monday, April 21st. William Blair reissued an "outperform" rating on shares of Stevanato Group in a research report on Monday, June 30th. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Stevanato Group has a consensus rating of "Moderate Buy" and a consensus target price of €25.70 ($29.88).

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.